跳至主要内容
欧盟官方标签名称词汇表条目 13194

HYDROXYAPATITE

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 2 个有匹配的监管证据:1 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。

2 个市场有证据
已检查的市场
13
有证据的市场
2
证据缺口
11
已解析的标识符
2

已解析的物质身份

CAS:1306-06-5
EC:215-145-7
成分索引记录:
HYDROXYAPATITE
化妆品功能: ABRASIVE, BULKING, ORAL CARE, SKIN CONDITIONING

Hydroxylapatite (Ca5(OH)(PO4)3)

CALCIUM HYDROXYAPATITE
化妆品功能: SKIN CONDITIONING

Durapatite (USAN)

5 个匹配或报告的名称
HYDROXYAPATITEdurapatiteCALCIUM HYDROXYAPATITEHydroxyapatite (nano)Hydroxyapatite

全部 13 个市场的监管证据

打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。

滑动或横向滚动以查看数据集覆盖范围和后续操作。

市场结果记录数据集含义 / 后续操作
European Union
EU
限用1打开记录 1
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
请查看每条关联记录及其确切条件。
Great Britain
GB
未找到匹配项0
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.
Canada
CA
未找到匹配项0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
未找到匹配项0
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative.
ASEAN
ASEAN
未找到匹配项0
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.
China
CN
未找到匹配项0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
未找到匹配项0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
未找到匹配项0
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
Korean source wording is canonical and other positive lists/notices may still apply to the formulation.
United States
US
未找到匹配项0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
未找到匹配项0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
未找到匹配项0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
未找到匹配项0
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
The standards are separate controlled publications; absence from a locally indexed excerpt is not permission.
Saudi Arabia
SA
Restricted1打开记录 1
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
请查看每条关联记录及其确切条件。
没有与此筛选条件匹配的市场行。

匹配的市场记录和条件

附件 II–VI 的精确证据

Annex III条目 372
打开完整监管记录

Hydroxyapatite (nano)

产品范围: (a) Toothpaste (b) Mouthwash

最大浓度: (a) 10 % (b) 0,465 %

限制: For (a) and (b): Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Only nanomaterials having the following characteristics are allowed: — [composed of] rod-shaped particles of which at least 95,8 % (in particle number) have an aspect ratio less than 3, and the remaining 4,2 % have an aspect ratio not exceeding 4,9; — the particles are not coated or surface modified

化学身份与性质

CAS 1306-06-5 的 PubChem 二维化学结构
CAS 1306-06-5PubChem CID 14781

Hydroxylapatite (Ca5(OH)(PO4)3)

Hydroxylapatite is a mineral with formula of Ca5(PO4)3OH. The corresponding IMA (International Mineralogical Association) number is IMA2010 s.p.. The IMA symbol is Hap. — RRUFF Project

IUPAC 名称
pentacalcium;hydroxide;triphosphate
分子式
Ca5HO13P3
分子量
502.3 g/mol
精确质量
501.675955 Da
拓扑极性表面积
260.0 Ų
氢键供体
1
氢键受体
13
共价单元
9
已定义的立体中心
0

又称

DurapatiteCalcium hydroxyapatiteRadiesseMoniteWin 40350Apatite, hydroxyCalcium hydroxylapatiteSupertite 10
另有 16 个已报告名称
Calcium phosphate hydroxideCalcium orthophosphate, basicPentacalcium monohydroxyorthophosphateInterpore200Interpore500215-145-7235-330-6Interpore 200Interpore 500Hydroxyapatite, CalciumOssein Hydroxyapatite CompoundOssopan 200Ossopan 800RefChem:56158HYDROXYAPATITEHydroxylapatite
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配14781

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 97.8% (362 of 370) of all reports. 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 362 of 370 companies (only 2.2% companies provided GHS information). For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 370 reports by companies from 5 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 362 of 370 reports by companies.; There are 3 notifications provided by 8 of 370 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Note: This chemical does not meet GHS hazard criteria for 94% (188 of 200) of all reports. 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 188 of 200 companies (only 6% companies provided GHS information). For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 200 reports by companies from 6 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 188 of 200 reports by companies.; There are 3 notifications provided by 12 of 200 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定